955406-82-3

Basic information

• Product Name: tert-butyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate
• Synonyms: tert-butyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate;2-Methyl-2-propanyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate
• CAS NO: 955406-82-3
• Molecular Formula: C₁₂H₁₉N₃O₂
• Molecular Weight: 237.29816
• Mol File: 955406-82-3.mol

Chemical Properties

• Boiling Point: 362.7±44.0 °C(Predicted)
• Appearance: /
• Density: 1.26±0.1 g/cm3(Predicted)
• PKA: 8.86±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate(955406-82-3)
• EPA Substance Registry System: tert-butyl 4-amino-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate(955406-82-3)

Safety Data

• Hazardous Substances Data: 955406-82-3(Hazardous Substances Data)

Upstream product

• 912259-10-0 1⁽²⁾,5,6,7-tetrahydro-4H-indazole-4-one 
• 955406-75-4 tert-butyl 4-oxo-4,5,6,7-tetrahydro-1H-indazole-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 955406-81-2 4-azido-4,5,6,7-tetrahydro-indazole-2-carboxylic acid tert-butyl ester 
• 955406-80-1 4-azido-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester 

Downstream Products

• 955406-85-6 (R)-4-[3-(4-benzyloxy-2,6-dichloro-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-2-carboxylic acid tert-butyl ester 
• 955406-84-5 (R)-4-[3-(4-benzyloxy-2,6-dichloro-benzyl)-2-oxo-pyrrolidin-1-yl]-4,5,6,7-tetrahydro-indazole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

MODULATORS OF LIPID STORAGE

Disclosed are compounds of formulas I, II, and III: Formulas I, II, and III wherein R1-R19 and n are as described herein, or pharmaceutically acceptable salts thereof, or an enantiomer thereof or a conjugate thereof wherein the conju

CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compound